Stem Cell Therapy
Stem cell therapy for advanced joint degeneration and chronic pain. Authorized under Florida law effective July 1, 2025.
Stem cell therapy at Cobblestone Spine and Joint Institute is now available under Florida CS/CS/SB 1768 (Chapter 2025-185), which took effect July 1, 2025. Yuleisy Coto, MSN, APRN, FNP-C (FL APRN License No. APRN11009024) administers these treatments at Cobblestone Spine for carefully selected patients with advanced joint degeneration, chronic disc disease, or soft tissue conditions that have not responded adequately to other interventions.
What Stem Cell Therapy Is
Stem cells are undifferentiated cells with the capacity to develop into specialized cell types. In orthopedic and musculoskeletal medicine, stem cell therapy introduces cells capable of differentiating into cartilage, bone, tendon, ligament, and disc tissue directly into areas where that tissue has been damaged or lost. The cells also release signaling molecules called cytokines and growth factors that modulate the local inflammatory environment and activate the body's resident repair cells.
This represents a fundamentally different mechanism from conventional treatments. Cortisone suppresses inflammation. Stem cell therapy introduces cells capable of participating directly in the structural repair and regeneration of damaged tissue.
How Stem Cell Therapy Works
Stem cell therapy uses cells with the capacity to differentiate into specialized tissue types and to release signaling molecules that coordinate the surrounding tissue's repair response. When introduced into a site of tissue damage, stem cells migrate toward the injury, reduce local inflammation, promote new blood vessel formation, and, depending on the tissue environment, differentiate into cells that contribute to structural repair. Results take longer than with most injections, typically three to six months for meaningful structural change.
Conditions Where Stem Cell Therapy Is Indicated
Advanced knee osteoarthritis with significant cartilage loss is the most common indication. A patient with bone-on-bone contact on imaging, moderate to severe functional limitation, and a strong preference to avoid joint replacement surgery is an appropriate stem cell candidate. Earlier-stage damage usually starts with simpler injections. When those have not produced an adequate response, or when imaging confirms advanced structural loss, stem cell therapy represents the next clinical step.
Significant hip osteoarthritis, major rotator cuff tears that are not full surgical candidates, and advanced disc degeneration unresponsive to spinal decompression and conservative care are also appropriate indications. Sacroiliac joint degeneration with significant ligamentous laxity, in patients where earlier injections have provided partial but incomplete improvement, can also benefit from stem cell therapy targeting the posterior SI ligamentous complex.
Who Is a Good Candidate for Stem Cell Therapy?
What to Expect
The procedure itself takes 60 to 90 minutes at the clinic. Results develop over three to six months as tissue repair progresses. Most patients do not experience dramatic immediate changes, which is expected given the mechanism. The healing response is biological rather than pharmacological. Follow-up evaluation at six to eight weeks, and again at three to four months, allows Yuleisy Coto to assess progress and determine whether additional intervention is warranted. Integration with chiropractic care during the recovery period addresses the mechanical loading patterns that contributed to the original degeneration.
60 to 90 minutes
The procedure itself
6 to 8 weeks
Follow-up evaluation
3 to 4 months
And again
3 to 6 months
Results develop